119 related articles for article (PubMed ID: 8195591)
41. The effects of domain deletion, glycosylation, and long IgG3 hinge on the biodistribution and serum stability properties of a humanized IgG1 immunoglobulin, hLL2, and its fragments.
Leung SO; Qu Z; Hansen HJ; Shih LB; Wang J; Losman MJ; Goldenberg DM; Sharkey RM
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3106s-3117s. PubMed ID: 10541351
[TBL] [Abstract][Full Text] [Related]
42. 111In-cetuximab-F(ab')2 SPECT and 18F-FDG PET for prediction and response monitoring of combined-modality treatment of human head and neck carcinomas in a mouse model.
van Dijk LK; Boerman OC; Franssen GM; Kaanders JH; Bussink J
J Nucl Med; 2015 Feb; 56(2):287-92. PubMed ID: 25552666
[TBL] [Abstract][Full Text] [Related]
43. Development and validation of an antigen-binding capture ELISA for native and putrescine-modified anti-tetanus F(ab')2 fragments for the assessment of the cellular uptake and plasma kinetics of the antibodies.
Welfringer F; d'Athis P; Scherrmann JM; Hervé F
J Immunol Methods; 2005 Dec; 307(1-2):82-95. PubMed ID: 16305797
[TBL] [Abstract][Full Text] [Related]
44. The isolation of immune complexes containing IgM rheumatoid factor and recovery of IgG rheumatoid factor from the complexes.
Jones VE; Cowley PJ; Allen C; Elson CJ
J Immunol Methods; 1980; 37(1):1-14. PubMed ID: 6776201
[TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetics of radioimmunotherapeutic agent of direct labeling mAb 188Re-HAb18.
Lou C; Chen ZN; Bian HJ; Li J; Zhou SB
World J Gastroenterol; 2002 Feb; 8(1):69-73. PubMed ID: 11833074
[TBL] [Abstract][Full Text] [Related]
46. Production and Characterization of F(Ab')
de Araujo AEV; de Souza NP; de Sousa APB; Lara FA; Senna JPM
Appl Biochem Biotechnol; 2018 May; 185(1):72-80. PubMed ID: 29082478
[TBL] [Abstract][Full Text] [Related]
47. Monoclonal antibody A7 tumor localization enhancement by its F(ab')2 fragments to colon carcinoma xenografts in nude mice.
Kitamura K; Takahashi T; Yamaguchi T; Kitai S; Amagai T; Imanishi J
Jpn J Clin Oncol; 1990 Jun; 20(2):139-44. PubMed ID: 2370692
[TBL] [Abstract][Full Text] [Related]
48. Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model.
Tahtis K; Lee FT; Smyth FE; Power BE; Renner C; Brechbiel MW; Old LJ; Hudson PJ; Scott AM
Clin Cancer Res; 2001 Apr; 7(4):1061-72. PubMed ID: 11309358
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of anti-IgM and growth factor-induced proliferation of guinea pig B cells by one of two distinct Fc gamma receptors on the cells.
Yamashita T; Koyama J
J Immunol; 1988 Nov; 141(9):2889-94. PubMed ID: 2971734
[TBL] [Abstract][Full Text] [Related]
50. Expression of immunoglobulin-cross-reactive molecules by neoplastic human T cells. I. Surface detection and isolation of molecules reactive with chicken anti-F(ab')2, anti-alpha and anti-mu antibodies.
Haegert DG; Timm M
Immunology; 1983 Nov; 50(3):447-59. PubMed ID: 6195097
[TBL] [Abstract][Full Text] [Related]
51. Demonstration of immunoglobulin-related molecules on human peripheral blood T lymphocytes using chicken anti-F(ab')2 and anti-IgM antibodies.
Haegert DG
Immunology; 1980 Nov; 41(3):663-71. PubMed ID: 6161876
[TBL] [Abstract][Full Text] [Related]
52. Photolinker-polymer-mediated immobilization of monoclonal antibodies, F(ab')2 and F(ab') fragments.
Gao H; Kislig E; Oranth N; Sigrist H
Biotechnol Appl Biochem; 1994 Oct; 20(2):251-63. PubMed ID: 7986381
[TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W
Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961
[TBL] [Abstract][Full Text] [Related]
54. Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor.
Burvenich IJ; Schoonooghe S; Blanckaert P; Bacher K; Vervoort L; Coene E; Mertens N; De Vos F; Slegers G
Nucl Med Biol; 2007 Apr; 34(3):257-65. PubMed ID: 17383575
[TBL] [Abstract][Full Text] [Related]
55. On the fragmentation of monoclonal IgG1, IgG2a, and IgG2b from BALB/c mice.
Parham P
J Immunol; 1983 Dec; 131(6):2895-902. PubMed ID: 6358356
[TBL] [Abstract][Full Text] [Related]
56. Different behaviour of mouse-human chimeric antibody F(ab')2 fragments of IgG1, IgG2 and IgG4 sub-class in vivo.
Buchegger F; Pèlegrin A; Hardman N; Heusser C; Lukas J; Dolci W; Mach JP
Int J Cancer; 1992 Feb; 50(3):416-22. PubMed ID: 1735611
[TBL] [Abstract][Full Text] [Related]
57. A protocol for 'enhanced pepsin digestion': a step by step method for obtaining pure antibody fragments in high yield from serum.
Jones RG; Landon J
J Immunol Methods; 2003 Apr; 275(1-2):239-50. PubMed ID: 12667687
[TBL] [Abstract][Full Text] [Related]
58. Blimp-1 overcomes the block in IgM secretion in lipopolysaccharide/anti-mu F(ab')2-co-stimulated B lymphocytes.
Schliephake DE; Schimpl A
Eur J Immunol; 1996 Jan; 26(1):268-71. PubMed ID: 8566078
[TBL] [Abstract][Full Text] [Related]
59. Phase I clinical evaluation of a new murine monoclonal antibody (Mu-9) against colon-specific antigen-p for targeting gastrointestinal carcinomas.
Sharkey RM; Goldenberg DM; Vagg R; Pawlyk D; Wong GY; Siegel JA; Murthy S; Levine GM; Izon D; Gascon P
Cancer; 1994 Feb; 73(3 Suppl):864-77. PubMed ID: 8306272
[TBL] [Abstract][Full Text] [Related]
60. Radiolocalization of human pancreatic tumors in athymic mice by monoclonal antibody DU-PAN 1.
Worlock AJ; Zalutsky MR; Metzgar RS
Cancer Res; 1990 Nov; 50(22):7246-51. PubMed ID: 2224857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
